Contact

Insights

The latest news in radiology AI

Understand the latest developments in AI image quantification

See how our software is supporting clinicians in healthcare institutions across the world, and meet the patients benefitting from precision volumetric analysis.

Filter by

Solution

Topic

Disease

  • < 1 mins

18 November 2023

Structural, functional & molecular neuroimaging biomarkers for AD

  • < 1 mins

18 November 2023

Biomarkers for the clinical evaluation of cognitive impairment

Research in Imaging in Medicine argues tests for amyloid when used in isolation are clinically useful only when evidence suggests progressive cognitive decline.

  • < 1 mins

18 November 2023

Neuroimaging in the evaluation of memory impairment

Authors Rahul Desikan et al from UCSD and UCSF describe a strategy to incorporate newly available imaging markers in the workup of memory problems

  • < 1 mins

18 November 2023

Predicting MCI Outcome With Clinically Available MRI And CSF Biomarkers

  • < 1 mins

18 November 2023

Mild cognitive impairment: improving predictive prognosis

Published in Radiology, this study assesses whether volumetric magnetic resonance (MR) imaging measures provide predictive prognostic information.

  • < 1 mins

18 November 2023

The contribution of MRI in assessing cognitive impairment in multiple sclerosis

  • < 1 mins

18 November 2023

Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study

  • < 1 mins

18 November 2023

Brain volumetry complements clinical evaluation of MS patients

The motivation of this study was to evaluate a new grouping scheme based on MS patients’ whole brain & thalamus volumes measured on MRI at a single time point.

  • < 1 mins

18 November 2023

Clinical relevance of brain volume measures in MS

This article reviews the current understanding of the implications of brain volume changes in MS, including the effects of disease-modifying treatments (DMTs).

  • < 1 mins

18 November 2023

Use of brain and spinal cord atrophy measures in clinical practice

MAGNIMS consensus recommendations: based on evidence, brain volume changes and, to a lesser extent, spinal cord atrophy are helpful predictors of MS evolution.

  • < 1 mins

18 November 2023

LesionQuant for assessment of MRI in MS

Study exploring whether utilizing software designed for evaluating MRI data in MS provides more accurate and detailed analyses compared to visual evaluation.

  • < 1 mins

18 November 2023

Translating research findings into clinical practice: a systematic and critical review of neuroimaging-based clinical tools for brain disorders

Our solutions

Advanced AI tools tailored for improved disease prediction and monitoring.

View all solutions

AI radiology news

Stay up to date with the latest insights, advances and clinical applications

Subscribe
“Utilizing NeuroQuant® in our health system has provided invaluable information, which leads to improved patient care.”

Dr. Ana Franceschi

Associate Professor, Radiology, Neuro-PET Imaging Lenox Hill Hospital

“NeuroQuant® is the clinical gold standard for MRI brain volume measurement.”

Dr. David E. Ross

Director, Virginia Institute of Neuropsychiatry

“Adding NeuroQuant® to our clinics has led to earlier diagnoses of neurodegenerative diseases with increased diagnostic confidence.”

Dr. Pablo Coimbra

Fortaleza General Hospital

“NeuroQuant® allows radiologists to quantify localized brain atrophy in minutes and compare to a large database of normal controls, which was previously not possible in a routine clinical setting.”

Dr. Sunil K. Ram

Neuroradiologist, Scottsdale Medical Imaging

Empowering precision

and clarity in patient care

5060 Shoreham Place,
Ste 240, San Diego, CA 92122

  • Solutions
  • © Cortechs.ai 2024
Scroll to Top